HK1003259A1 - Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections - Google Patents

Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections

Info

Publication number
HK1003259A1
HK1003259A1 HK98102406A HK98102406A HK1003259A1 HK 1003259 A1 HK1003259 A1 HK 1003259A1 HK 98102406 A HK98102406 A HK 98102406A HK 98102406 A HK98102406 A HK 98102406A HK 1003259 A1 HK1003259 A1 HK 1003259A1
Authority
HK
Hong Kong
Prior art keywords
prophylaxis
treatment
antiviral agents
herpesvirus infections
aminopurine
Prior art date
Application number
HK98102406A
Other languages
English (en)
Inventor
Hugh John Field
Alana Maureen Thackray
Teresa Helen Bacon
David Sutton
Hodge Richard Anthony Vere
Original Assignee
Novartis Int Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27451235&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1003259(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9425012.3A external-priority patent/GB9425012D0/en
Priority claimed from GBGB9506663.5A external-priority patent/GB9506663D0/en
Priority claimed from GBGB9517308.4A external-priority patent/GB9517308D0/en
Application filed by Novartis Int Pharm Ltd filed Critical Novartis Int Pharm Ltd
Publication of HK1003259A1 publication Critical patent/HK1003259A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK98102406A 1994-12-12 1998-03-20 Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections HK1003259A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9425012.3A GB9425012D0 (en) 1994-12-12 1994-12-12 Pharmaceuticals
GBGB9506663.5A GB9506663D0 (en) 1995-03-31 1995-03-31 Pharmaceuticals
GBGB9517308.4A GB9517308D0 (en) 1995-08-24 1995-08-24 Pharmaceuticals
US08/522,790 US5840763A (en) 1994-12-12 1995-09-01 Treatment of a latent infection of herpes viruses
PCT/EP1995/004692 WO1996018396A1 (en) 1994-12-12 1995-11-23 Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections

Publications (1)

Publication Number Publication Date
HK1003259A1 true HK1003259A1 (en) 1998-10-23

Family

ID=27451235

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98102406A HK1003259A1 (en) 1994-12-12 1998-03-20 Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections

Country Status (24)

Country Link
US (2) US5840763A (pt)
EP (1) EP0799039B1 (pt)
JP (1) JP2008088189A (pt)
CN (1) CN1098687C (pt)
AP (1) AP669A (pt)
AT (1) ATE208198T1 (pt)
AU (1) AU699627B2 (pt)
BG (1) BG63815B1 (pt)
BR (1) BR9509986A (pt)
CA (1) CA2207503C (pt)
CY (1) CY2339B1 (pt)
CZ (1) CZ291545B6 (pt)
DE (1) DE69523776T2 (pt)
DK (1) DK0799039T3 (pt)
ES (1) ES2166834T3 (pt)
HK (1) HK1003259A1 (pt)
HU (1) HU222835B1 (pt)
NO (1) NO313862B1 (pt)
NZ (1) NZ297424A (pt)
PT (1) PT799039E (pt)
RO (1) RO120042B1 (pt)
SI (1) SI0799039T1 (pt)
SK (1) SK282983B6 (pt)
WO (1) WO1996018396A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
US6047209A (en) * 1999-04-02 2000-04-04 Denny; Jeffrey Paul Method and apparatus for maintenance of pierced orifices
CA2602691A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
AU2006230269A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
WO2007037790A2 (en) * 2005-06-08 2007-04-05 Elan Corporation, Plc Modified release famciclovir compositions
EP3753563A1 (en) * 2019-06-20 2020-12-23 Helmholtz-Zentrum für Infektionsforschung GmbH Anti-herpesvirus guanosine analogue for the inhibition of basal autophagy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses

Also Published As

Publication number Publication date
DK0799039T3 (da) 2002-01-28
US5840763A (en) 1998-11-24
US5916893A (en) 1999-06-29
AP669A (en) 1998-09-04
EP0799039A1 (en) 1997-10-08
PT799039E (pt) 2002-04-29
CZ179997A3 (en) 1997-09-17
JP2008088189A (ja) 2008-04-17
WO1996018396A1 (en) 1996-06-20
MX9704336A (es) 1997-09-30
NO313862B1 (no) 2002-12-16
CN1098687C (zh) 2003-01-15
NO972688L (no) 1997-08-07
BG63815B1 (bg) 2003-02-28
HUT77437A (hu) 1998-04-28
CY2339B1 (en) 2004-02-06
HU222835B1 (hu) 2003-11-28
SK282983B6 (sk) 2003-01-09
CZ291545B6 (cs) 2003-04-16
AU4257896A (en) 1996-07-03
RO120042B1 (ro) 2005-08-30
ES2166834T3 (es) 2002-05-01
CA2207503C (en) 2006-07-18
ATE208198T1 (de) 2001-11-15
BG101608A (en) 1998-02-27
AU699627B2 (en) 1998-12-10
SI0799039T1 (en) 2002-06-30
CA2207503A1 (en) 1996-06-20
CN1175212A (zh) 1998-03-04
DE69523776T2 (de) 2002-08-01
SK75197A3 (en) 1997-11-05
NO972688D0 (no) 1997-06-11
NZ297424A (en) 2000-07-28
BR9509986A (pt) 1997-11-25
AP9701001A0 (en) 1997-07-31
DE69523776D1 (de) 2001-12-13
EP0799039B1 (en) 2001-11-07

Similar Documents

Publication Publication Date Title
ZA9410078B (en) Methods of inhibiting atrophy of the skin and vagina
AP9300603A0 (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
HK1022269A1 (en) Use of 1-hydroxy-2-pyridones in the manufacture of a medicament for treating skin infections
GB9304746D0 (en) Treatment of viral infections
GB9409336D0 (en) Use of an enzyme for manufacturing an agent for the treatment and/or prophylaxis of coccidiosis
HK1003259A1 (en) Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections
EP0797440A4 (en) TREATING AUTOIMMUNE DISEASES WITH THE AID OF 2-AMINOPURINE DERIVATIVES
HK1004527A1 (en) Penciclovir and famciclovir and related guanine derivatives for the treatment of the hiv-1 infections
AU6748090A (en) Use of caffeine in the treatment of herpes simplex virus infections
IL125075A (en) Penciclovir or famciclovir in combination with immunosuppressants in the treatment of herpes simplex virus infections
GB9419692D0 (en) Treatment of herpes infections
EP0546261A3 (en) Method of treating latent herpes viral infections
IL120997A0 (en) Use of theophylline derivatives for the treatment and prophylaxis of states of shock novel xanthine compounds and processes for their preparation
AU4812393A (en) Use of rapamycin in the treatment of aids
AU4319393A (en) Use of indolocarbazols in aids treatment
GB2279567B (en) Compositions for the treatment of inflammatory proliferative skin disease and their use
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
GB9711848D0 (en) Treatment and prophylaxis of infraction
ZA939356B (en) Use of CN-substituted benzimidazoles
AP9400628A0 (en) Therapeutic triazine compounds and use
GB9603657D0 (en) Improvements in the treatment of vaginal infections
GB9305693D0 (en) Therapeutic triazine compounds and use
SI0814813T1 (en) Use of penciclovir for the treatment of human herpes-virus-8
EP0452941A3 (en) Use of isomonools in the treatment and prophylaxis of cancer
ZA941244B (en) Selective treatment of enteroviral-caused infections in humans

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20151122